| 000 | 03688cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031717.0 | ||
| 008 | 170419s2016 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.30.M.Sc.2016.Mo.E | ||
| 100 | 0 | _aMona Mohamed Ahmed Ahmed | |
| 245 | 1 | 0 |
_aEffect of apelin on obesity- associated type2 diabetes mellitus in male albino rats. possible interaction between APELIN/APJ system, renin angiotensin system and nitric oxide / _cMona Mohamed Ahmed Ahmed ; Supervised Maha Mohamed Sabry , Manal Moustafa Mahmoud , Heba Samy Ibrahim |
| 246 | 1 | 5 | _aتأثير الأبيلين على مرض السكرى من النوع الثانى المصاحب للسمنه فى ذكور الفئران البيضاء واحتمال تفاعل بين نظام الأبيلين ونظام الرينين /انجوتنسين و أكسيد النيتريك |
| 260 |
_aCairo : _bMona Mohamed Ahmed Ahmed , _c2016 |
||
| 300 |
_a191 p. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Physiology | ||
| 520 | _aBackground: Apelin, a recently identified adipokine, and its receptor (APJ) are involved in the regulation of a variety of pathphysiological processes. APJ shares marked sequence homology with angiotensin II type 1 receptor (ATR1) and both receptors are expressed in many different tissues. Objective: the purpose of the present study is to evaluate the effect of apelin treatment on obesity-induced type 2 diabetes mellitus (T2DM) and the possible interaction between apelin/APJ system and renin angiotensin system (RAS) with a particular focus on their relation with endothelial nitric oxide synthase (eNOS) pathway. Methods: forty male albino rats were divided in to 2 groups. Control group (n=8) and diabetic group (n=32). Diabetic group were further subdivided in to four groups; control diabetic group (n=8), apelin treated diabetic group (n=8), apelin+losartan treated diabetic group (n=8), apelin+L-NAME treated diabetic group (n=8). Rats in diabetic group were fed high fat high sucrose (HF-HS) diet for six weeks to induce obesity and insulin resistance (IR) + single low dose of streptozotocin (STZ, 35 mg/kg) at the end of fifth week to induce T2DM. Drugs were given from the start and continued for one week after STZ injection. Apelin-13 was given intraperitoneal (0.1omol/kg /day). Losrtan, angiotensin II type 1 receptor blocker, was given orally (30 mg/kg/day). L-NG-nitroarginine methyl ester (L-NAME), non specific eNOS inhibitor, was given intraperitoneal (10 mg/kg/day). At the end of the study body mass index (BMI) was calculated and blood samples were taken to measure serum Glucose, Insulin, Lipid profile {cholesterol, Triglycerides (TGs), High density lipoprotein (HDL), inflammatory marker: Tumor necrosis factor-Ü (TNFÜ), oxidative stress marker: Malondialdehyde (MDA), endothelial dysfunction marker: Tissue plasminogen activator (T-PA) antigen, and Nitric oxide (NO) levels. After decapitation, adipose tissue was taken for the determination of gene expression of (ATR1) and angiotensin converting enzyme 2 (ACE2) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAngiotensin system (RAS) | |
| 653 | 4 | _aApelin, Renin | |
| 653 | 4 | _aType 2 Diabetes Mellitus (T2DM) | |
| 700 | 0 |
_aHeba Samy Ibrahim , _eSupervisor |
|
| 700 | 0 |
_aMaha Mohamed Sabry , _eSupervisor |
|
| 700 | 0 |
_aManal Moustafa Mahmoud , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aShaima _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c60691 _d60691 |
||